Cargando…
Pharmacal Failings
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
1880
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461853/ https://www.ncbi.nlm.nih.gov/pubmed/36667285 |
Ejemplares similares
-
Comment on “Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following its 20th Anniversary”: Clarification from PHARMAC: PHARMAC Takes No Particular Distributive Approach (Utilitarian or Otherwise)
por: Metcalfe, Scott, et al.
Publicado: (2014) -
NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19
Publicado: (2021) -
NZ's Pharmac negotiates deal for molnupiravir to treat COVID-19
Publicado: (2021) -
NZ's Pharmac to fund tocilizumab for moderate-to-severe cases of COVID-19
Publicado: (2021) -
NZ's Pharmac negotiates deal for Roche's monoclonal antibodies for COVID-19
Publicado: (2021)